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Abstract Glycosylphosphatidylinositol-anchored high-
density lipoprotein-binding protein 1 (GPIHBP1) functions
as a platform and transport agent for lipoprotein lipase
(LPL) which functions in the hydrolysis of chylomicrons,
principally in heart, skeletal muscle and adipose tissue
capillary endothelial cells. Previous reports of genetic
deﬁciency for this protein have described severe chylomi-
cronemia. Comparative GPIHBP1 amino acid sequences
and structures and GPIHBP1 gene locations were exam-
ined using data from several mammalian genome projects.
Mammalian GPIHBP1 genes usually contain four coding
exons on the positive strand. Mammalian GPIHBP1
sequences shared 41–96% identities as compared with
9–32% sequence identities with other LY6-domain-con-
taining human proteins (LY6-like). The human N-glyco-
sylation site was predominantly conserved among other
mammalian GPIHBP1 proteins except cow, dog and pig.
Sequence alignments, key amino acid residues and con-
served predicted secondary structures were also examined,
including the N-terminal signal peptide, the acidic amino
acid sequence region which binds LPL, the glycosylpho-
sphatidylinositol linkage group, the Ly6 domain and the
C-terminal a-helix. Comparative and phylogenetic studies
of mammalian GPIHBP1 suggested that it originated in
eutherian mammals from a gene duplication event of an
ancestral LY6-like gene and subsequent integration of exon
2, which may have been derived from BCL11A (B-cell
CLL/lymphoma 11A gene) encoding an extended acidic
amino acid sequence.
Keywords Mammals   Amino acid sequence  
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Introduction
Recent studies (Ioka et al. 2003; Beigneux et al. 2007) have
shown that a glycosylphosphatidylinositol-anchored high-
density lipoprotein-binding protein 1 (GPIHBP1) of capil-
lary endothelial cells is required for the metabolism of
triglyceride-rich lipoproteins in mammalian plasma. This
glycoprotein binds lipoprotein lipase (LPL) and apolipo-
proteins (apoA-V) strongly (Gin et al. 2007, 2011) and may
serve as a platform for lipolysis within capillaries, particu-
larly in tissues which show high expression levels for both
GPIHBP1 andLPLgenes, suchasheart, skeletalmuscleand
adipose tissue (Beigneux et al. 2007; Wion et al. 1987;
Havel and Kane 2001; Young et al. 2007). Studies of
Gpihbp1
-/Gpihbp1
- knock out mice have shown that
GPIHBP1-deﬁciency causes severe hypertriglyceridemia
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DOI 10.1007/s13205-011-0026-4with very high plasma triglyceride levels of 2,000–
5,000 mg/dl (Beigneux et al. 2007; Young et al. 2007).
Human clinical studies have also examined loss of
function GPIHBP1 mutations leading to familial chylo-
micronemia. Wang and Hegele (2007) reported two
siblings with severe chylomicronemia of 160 patients
examined exhibiting chylomicronemia who were homo-
zygous for a GPIHBP1 gene missense mutation (G56R).
Franssen et al. (2010) and Olivecrona et al. (2010) have
recently identiﬁed mutations of conserved cysteines (C65S,
C65Y and C68G) in the Ly6 domain of GPIHBP1 in
familial chylomicronemia, while Beigneux et al. (2009)
have reported a mutant GPIHBP1 (Q115P) which lacked
the ability to bind LPL and chylomicrons in a patient with
chylomicronemia.
Biochemical studies (Beigneux et al. 2007; Gin et al.
2007, 2011) have suggested that GPIHBP1 is localized on
theluminalandabluminal capillary endothelialcellsurfaces
where it is bound by a glycosylphosphatidylinositol anchor
and binds strongly to LPL. GPIHBP1 serves as an LPL
transporter from the sub-endothelial spaces to the luminal
face of capillaries, enabling lipolysis of circulating tri-
glycerides localized within plasma chylomicrons (Davies
et al. 2010; Fisher 2010). Molecular modeling of human
GPIHBP1 (Beigneux et al. 2007) and biochemical analyses
(Gin et al. 2007) have shown that this protein contains at
least four major domains with distinct roles: an N-terminal
signal peptide which targets the intracellular trafﬁcking of
GPIHBP1 to the cell surface via the endoplasmic reticulum;
a very acidic amino acid domain within the GPIHBP1
amino-terminal region may play a role in binding to the
positively charged residues of the heparin-binding domain
for LPL and apolipoproteins; a cysteine-rich LY6 domain
also contributes to LPL binding, as shown by site-directed
mutagenesis and human clinical mutation studies (Franssen
et al. 2010; Olivecrona et al. 2010); and a C-terminal region
which contains a hydrophobic domain which is replaced by
a glycosylphosphotidylinositol anchor within the endo-
plasmic reticulum and which binds GPIHBP1 to the endo-
thelial cell surface (Nosjean et al. 1997; Fisher 2010; Ory
2007). Recently, Gin et al. (2011) have reported several
important GPIHBP1-binding properties and have shown
speciﬁc binding for LPL whereas other related neutral
lipases, hepatic lipase (HL) and endothelial lipase (EL), do
notbind.Inaddition,GPIHBP1alsobindsAPO-A5strongly
whereas another lipid transport protein (APO-A1) does not.
Structures of mammalian GPIHBP1 genes have been
reported in association with a number of mammalian
genome sequencing projects, including human, mouse and
rat (Mammalian Genome Project Team 2004; Rat Genome
Sequencing Project Consortium 2004), and some mam-
malian GPIHBP1 cDNA and protein sequences have been
described (Ioka et al. 2003; Beigneux et al. 2007; Beigneux
et al. 2009a, b). Human, mouse and rat GPIHBP1 genes
contain four exons of DNA encoding GPIHBP1 sequences
(Thierry-Mieg and Thierry-Mieg 2006).
This paper describes predicted gene structures and amino
acid sequences for several mammalian GPIHBP1 genes and
proteins, and predicted secondary structures for mammalian
GPIHBP1 proteins. In addition, we examine the relatedness
for mammalian GPIHBP1 with other lymphocyte antigen-6
(Ly6-like) genes and proteins, and describe an hypothesis
for the origin of the GPIHBP1 gene within eutherian
mammals from an ancestral mammalian LY6-like gene and
subsequent integration of an exon within the mammalian
GPIHBP1 gene encoding the acidic amino acid LPL-bind-
ing platform previously described for human and mouse
GPIHBP1 (Beigneux et al. 2007; Gin et al. 2007, 2011).
Methods
Mammalian GPIHBP1 gene and protein identiﬁcation
Basic Local Alignment Search Tool (BLAST) studies were
undertaken using web tools from the National Center for
Biotechnology Information (NCBI) (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) (Altschul et al. 1997). Protein BLAST
analyses used mammalian GPIHBP1 amino acid sequences
previously described (Table 1). Non-redundant protein
sequence databases for several mammalian genomes were
examined using the blastp algorithm, including human
(Homo sapiens) (International Human Genome Consortium
2001); chimpanzee (Pan troglodytes) (Chimpanzee
Sequencing and Analysis Consortium 2005); orangutan
(Pongo abelii)( http://genome.wustl.edu); rhesus monkey
(Macaca mulatta) (Rhesus Macaque Genome Sequencing
and Analysis Consortium 2007), cow (Bos Taurus) (Bovine
Genome Project 2008); horse (Equus caballus) (Horse
Genome Project 2008); mouse (Mus musculus) (Mouse
Genome Sequencing Consortium 2002); rat (Rattus nor-
vegicus) (Rat Genome Sequencing Project Consortium
2004); opossum (Monodelphis domestica) (Mikkelsen et al.
2007); and platypus (Ornithorhynchus anatinus) (Warren
etal.2008).ThisprocedureproducedmultipleBLAST‘hits’
for each of the protein databases which were individually
examined and retained in FASTA format, and a record kept
of the sequences for predicted mRNAs and encoded
GPIHBP1-like proteins. These records were derived from
annotated genomic sequences using the gene prediction
method: GNOMON and predicted sequences with high
similarityscoresforhumanGPIHBP1.PredictedGPIHBP1-
like protein sequences were obtained in each case and sub-
jected to analyses of predicted protein and gene structures.
Blast-Like Alignment Tool (BLAT) analyses were sub-
sequently undertaken for each of the predicted GPIHBP1
38 3 Biotech (2012) 2:37–52
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123amino acid sequences using the University of California
Santa Cruz (UCSC) Genome Browser [http://genome.ucsc.
edu/cgi-bin/hgBlat] (Kent et al. 2003) with the default set-
tings to obtain the predicted locations for each of the
mammalian GPIHBP1 genes, including predicted exon
boundary locations and gene sizes. BLAT analyses were
similarly undertaken for other mammalian LY6-like and
vertebrate BCL11A-like (encoding B-cell CLL/lymphoma
11A) genes and proteins using previously reported sequen-
ces for LY6D, LY6E, LY6H, LY6K, LY6NX1, PSCA,
SLURP1, GML, LY6D2 and BCL11A in each case
(Tables 1, 2, 3). Structures for human, mouse and rat
GPIHBP1 genes and encoded proteins were obtained using
theAceViewwebsiteThierry-MiegandThierry-Mieg2006)
(http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/index.
html?human).
Predicted structures, properties and alignments
of mammalian GPIHBP1 and human LY6-like
sequences
Predicted secondary structures for human and other mam-
malian GPIHBP1 proteins were obtained using the PSI-
PRED v2.5 website tools [http://bioinf.cs.ucl.ac.uk/psipred/
psiform.html] (McGufﬁn et al. 2000). Other web tools were
used to predict the presence and locations of the following
for each of the mammalian GPIHBP1 sequences: SignalP
3.0 for signal peptide cleavage sites (http://www.cbs.
dtu.dk/services/SignalP/) (Emmanuelsson et al. 2007);
NetNGlyc 1.0 for potential N-glycosylation sites (http://
www.cbs.dtu.dk/services/NetNGlyc/); and big-PI Predictor
for the glycosylphosphatidylinositol linkage group-
anchored sites (http://mendel.imp.ac.at/sat/gpi/gpi_server.
html) (Eisenhaber et al. 1998). The reported tertiary
structure for human CD59 (membrane-bound glycoprotein)
(Leath et al. 2007) served as the reference for the predicted
human, rat, pig and guinea pig GPIHBP1 tertiary struc-
tures, with modeling ranges of residues 62–138, 69–146,
65–141 and 61–139, respectively. Alignments of mam-
malian GPIHBP1 sequences with human LY6D, LY6E,
LY6H, LY6K, LYNX1 and LYPD2 lymphocyte antigen-6-
related proteins or with vertebrate B-cell CLL/lymphoma
11A (BCL11A) sequences were assembled using the Clu-
stalW2 multiple sequence alignment program (Larkin et al.
2007)( http://www.ebi.ac.uk/Tools/clustalw2/index.html).
Comparative bioinformatics of mammalian GPIHBP1,
vertebrate LY6-like and vertebrate BCL11A genes
and proteins
The UCSC Genome Browser (http://genome.ucsc.edu)
(Kent et al. 2003) was used to examine comparative
structures for mammalian GPIHBP1 (Table 1), vertebrate
LY6-like (lymphocyte antigen-6 complex; Tables 1, 2) and
vertebrate BCL11A (B-cell CLL/lymphoma 11A) (Table 3)
genes and proteins. We also used the UCSC Genome
Browser Comparative Genomics track that shows align-
ments of up to 28 vertebrate species and evolutionary
conservation of GPIHBP1 gene sequences. Species aligned
for this study included 4 primates, 6 non-primate eutherian
mammals (e.g., mouse, rat), a marsupial (opossum), a
monotreme (platypus) and bird species (chicken). Conser-
vation measures were based on conserved sequences across
all of these species in the alignments which included the 50-
ﬂanking, 50-untranslated and coding regions of the
GPIHBP1 gene.
BLAT analyses were subsequently undertaken using the
nucleotide sequence for exon 2 of human GPIHBP1 using
t h eU C S CG e n o m eB r o w s e r[ http://genome.ucsc.edu/cgi-bin/
hgBlat] (Kent et al. 2003) to identify homologs for this exon
in the human genome.
Phylogenetic studies and sequence divergence
Alignments of mammalian GPIHBP1 and vertebrate LY6-
like protein sequences were assembled using BioEdit
v.5.0.1 and the default settings (Hall 1999). Alignment
ambiguous regions, including the acidic amino acid region
of GPIHBP1, were excluded prior to phylogenetic analysis
yielding alignments of 60 residues for comparisons of
sequences with the zebraﬁsh (Danio rerio) LY6-like
(LYPD6) sequence (Tables 1, 2). Evolutionary distances
were calculated using the Kimura option (Kimura 1983)i n
TREECON (Van De Peer and de Wachter 1994). Phylo-
genetic trees were constructed from evolutionary distances
using the neighbor-joining method (Saitou and Nei 1987)
and rooted with the zebraﬁsh LYPD6 sequence. Tree
topology was reexamined by the bootstrap method (100
bootstraps were applied) of resampling and only values that
were highly signiﬁcant (C90) are shown (Felsenstein
1985).
Results and discussion
Alignments of mammalian GPIHBP1 amino acid
sequences with human LY6-related antigen sequences
The deduced amino acid sequences for orangutan (Pongo
abelii), rhesus monkey (Macaca mulatta), marmoset
(Callithrix jacchus), horse (Equus caballus), cow (Bos
taurus) and rat (Rattus norvegicus) GPIHBP1 are shown in
Fig. 1 together with previously reported sequences for
human and mouse GPIHBP1 (Beigneux et al. 2007; Gin
et al. 2007). In addition, amino acid sequences for several
LY6-related lymphocyte antigen sequences are also
40 3 Biotech (2012) 2:37–52
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123aligned with the mammalian GPIHBP1 sequences,
including human LY6D (Brakenoff et al. 1995), LY6E
(Capone et al. 1996), LYPD2 (Clark et al. 2003), LY6H
(Horie et al. 1998), LY6K (Ishikawa et al. 2007) and
LYNX1 (Mammalian Genome Project Team 2004)
(Table 1). Alignments of human and other mammalian
GPIHBP1 sequences examined showed identities between
46 and 96%, suggesting that these are the products of the
same gene family, whereas comparisons of sequence
identities of mammalian GPIHBP1 proteins with human
LY6-like lymphocyte antigen sequences exhibited low
levels of sequence identities (9–32%), indicating that these
are the members of distinct protein families (Table 4).
The amino acid sequences for most of the mammalian
GPIHBP1 proteins contained 167–184 residues whereas
mouse and rat GPIHBP1 contained 225 and 236 amino
acids, respectively, with the latter having extended C-ter-
minal sequences (Fig. 1). Previous biochemical and genetic
analyses of human and mouse GPIHBP1 (Beigneux et al.
2007; Gin et al. 2007, 2011) have enabled predictions of key
residues for these mammalian GPIHBP1 proteins (sequence
numbers refer to human GPIHBP1). These included the
N-terminus signal peptide (residues 1–20) which partici-
pates in the trafﬁcking of GPIHBP1 via the endoplasmic
reticulum; two acidic amino acid clusters (residues 25–32
and 41–50) which may contribute to LPL binding within a
basic amino acid LPL heparin-binding site region (Sendak
and Bensadoun 1998); a conserved Gly56 with an unknown
function (Gin et al. 2007); a predominantly conserved
N-glycosylation site (Asn78-Leu79-Thr80) which is critical
for the movement of GPIHBP1 onto the cell surface
(Beigneux et al. 2008); a urokinase plasminogen activator
receptor (UPAR)-lymphocyte antigen-6 (LY6) domain
which contains 10 conserved cysteine residues (Cys65,
Cys68, Cys77, Cys83, Cys89, Cys110, Cys114, Cys130,
Cys131 and Cys136) and forms ﬁve disulﬁde bridges within
this domain; Gln115 which plays a role in LPL binding
to GPIHBP1 (Franssen et al. 2010); and a hydrophobic
C-terminal helix domain (residues 160–178) which is
replaced by a glycosylphosphatidylinositol anchor (to
Gly159) and is responsible for linking GPIHBP1 to the
endothelial cell surface (Nosjean et al. 1997; Davies et al.
2010; Fisher 2010). These residues and predicted properties
were conserved for all of the mammalian GPIHBP1
sequences examined (Fig. 1) with the exception of the cow
GPIHBP1 sequence, which lacked a predicted N-glycosyl-
ation site (Beigneux et al. 2008). Predicted N-glycosylation
site(s) were also absent in guinea pig, dog and pig GPIHBP1
sequences; whereas human and orangutan GPIHBP1
sequences exhibited two predicted N-glycosylation sites
(Asn78-Leu79-Thr80 and Asn82-Cys83-Ser84) (Table 5)
although experimental evidence for in vivo N-glycosylation
is only available for the ﬁrst site (Beigneux et al. 2008).
The human LY6-like sequences examined shared sev-
eral of the mammalian GPIHBP1 domain regions, includ-
ing the N-signal peptide region (sequence numbers refer to
human LY6D) (residues 1–20); the UPAR-LY6 domain
with 10 conserved cysteine residues (Cys23, Cys26, Cys32,
Cys38, Cys45, Cys63, Cys67, Cys86, Cys87 and Cys92)
forming ﬁve disulﬁde bonds previously reported for
Table 3 Vertebrate BCL11A genes and proteins
Mammalian
BCL11A
Gene
Species RefSeq ID
Ensembl
a
GenBank
ID
UNIPROT
ID
Amino
acids
Chromosome
location
Coding exons
(strand)
Gene
size bps
Human Homo sapiens NM_018014 BC021098 Q9H165 773 2:60,678,303-60,780,633 5 (-ve) 102,331
Orangutan Pongo abelii XP_002812058
a na na 808 2:50,366,387-50,465,154 6 (?ve) 98,768
Marmoset Callithrix jacchus XP_002757779
a na na 808 14:46,690,157-46,792,384 6 (?ve) 102,228
Mouse Mus musculus NM_016707 BC010585 Q9QYE3 773 11:23,978,391-24,072,787 5 (?ve) 94,397
Pig Sus scrofa XP_003125157
a AK231444 na 773 3:74,933,998-75,031,771 5 (?ve) 97,774
Rabbit Oryctolagus cuniculus XP_002709742
a na na 821 2:125,646,621-125,730,521 4 (?ve) 83,901
Dog Canis familiaris XP_865536
a na na 773 10:63,737,516-63,836,852 5 (-ve) 99,337
Chicken Gallus gallus NM_001031031 AJ551441 Q5F459 796 3:1,829,458-1,877,784 3 (-ve) 48,237
Lizard Anolis carolinensis XP_003216184
a na na 796 276:252,030-507,710
b 3( ?ve) 255,681
Zebraﬁsh Danio rerio NP_001035481
a na A2BE84 829 13:26,077,202-26,148,770 3 (?ve) 71,569
BCL11A refers to the gene encoding vertebrate B-cell CLL/lymphoma 11A sequences
Ensemble ID was derived from Ensembl genome database http://www.ensembl.org; UNIPROT refers to UniprotKB/Swiss-Prot IDs for indi-
vidual proteins (see http://kr.expasy.org); bps refers to base pairs of nucleotide sequences; the number of coding exons are listed
RefSeq The reference amino acid sequence
a Predicted Ensembl amino acid sequence
b Refers to scaffold ID
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123LY6-like proteins (Fry et al. 2003; Leath et al. 2007), and
the hydrophobic C-terminal helix domain (residues
104–125) which is replaced by a glycosylphosphati-
dylinositol anchor (predicted to be bound to Asn98). These
LY6-like sequences, however, lacked the N-terminal acidic
amino acid domain and contained fewer amino acids in the
protein region surrounding the UPAR-Ly6 domain (resi-
dues 21–96). These sequences also lacked the predomi-
nantly conserved N-glycosylation site observed for
mammalian GPIHBP1 proteins but contained amidation
sites for attaching the glycosylphosphatidylinositol anchor
in each case.
Predicted structures for mammalian GPIHBP1 proteins
Predicted secondary structures for mammalian GPIHBP1
sequences were compared with those predicted for human
lymphocyte antigen-6-like proteins (Fig. 1). a-Helix and
b-sheet structures for these sequences were similar for
several regions with the human LY6-like secondary
structures, including the N-terminal signal peptide which
contained an extended helical structure; the UPAR-LY6
domain which contained four or ﬁve b-sheet structures
(designated as b1–b5) within the region for ﬁve disulﬁde
bonds; and the C-terminal hydrophobic region, which is
Fig. 1 Amino acid sequence alignments for mammalian GPIHBP1
and human LY6-like sequences. See Table 1 for sources of
glycosylphosphatidylinositol-anchored high-density lipoprotein-bind-
ing protein 1 (GPIHBP1) and human LY6-like sequences:
GPIHBP1—Hu human, Or orangutan, Rh rhesus, Ma marmoset, Ho
horse, Co cow, Mo mouse, Ra rat; Human LY6-like: 6D-LY6D;
6E-LY6E; 6D2-LY6D2; 6H-LY6H; 6K-LY6K; 6NX-LY6NX. Aster-
isks show identical residues for proteins, colon similar alternate
residues, dot dissimilar alternate residues. Residues predicted for
involvement in N-signal peptide formation are shown in red,
N-glycosylated and potential N-glycosylated Asn sites are in green
bold, key GPIHBP1 functional residues 56Gly and 114Gln are in
shaded pink, predicted disulﬁde bond Cys residues are shown;
a-helices predicted for GPIHBP1 are in shaded yellow, b-sheets
(b1–b5) predicted for mammalian GPIHBP1 or for human LY6-like
sequences are in shaded grey, bold underlined font shows residues
corresponding to known or predicted exon start sites. Exon numbers
refer to GPIHBP1 human gene exons, the sequences for the UPAR/
Ly6 domain are shown, C-terminal hydrophobic amino acid segment
is shown as shaded green, known (human and mouse) or predicted
mammalian GPIHBP1 and human LY6-like GPI-binding sites are
shown in shaded blue
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123removed following GPI-attachment within the endoplasmic
reticulum. The distinctive secondary structures observed
for mammalian GPIHBP1 sequences were two acidic
amino acid a-helical regions which were notably absent in
the LY6-like predicted secondary structures.
Tertiary structures for the members of the LY6 protein
family has been reported previously which are character-
ized by an amino acid motif containing eight or ten cys-
teine residues arranged in consistent spacing patterns
forming four or ﬁve disulﬁde bonds and a three-ﬁnger
motif which comprised b-pleated sheets predominantly.
The predicted secondary structures observed for the human
LY6-like proteins (LY6D, LY6E, LY6PD, LY6H, LY6K
and LY6NX1) and the mammalian GPIHBP1 protein
sequences examined are consistent with the presence of
this LY6 protein family motif within these proteins
(Fig. 1). Figure 2 describes predicted tertiary structures for
human, rat, pig (Sus scrofa) and guinea pig (Cavia por-
cellus) GPIHBP1 protein sequences and shows signiﬁcant
similarities to the UPAR-LY6 domain reported for the
human CD59 antigen (membrane-bound glycoprotein)
(Leath et al. 2007). Five anti-parallel b-sheets are readily
apparent in each case, which is consistent with the pre-
dictions observed for the human and rat GPIHBP1 proteins
shown in the amino acid sequence alignments in Fig. 1.
This suggests that the UPAR-LY6 domain secondary and
tertiary structures are shared among all GPIHBP1 proteins
examined as well as the human LY6-like proteins
examined.
The overall structure for mammalian GPIHBP1 may then
comprise the two a-helices of acidic amino acids (which
bind LPL to GPIHBP1) and the three-ﬁngered b-sheet motif
which is covalently linked to the plasma membrane by a
glycosylphosphatidylinositol anchor. Recent studies have
shown that both motifs are essential for LPL binding and
transport and for GPIHBP1 function (Beigneux et al. 2009a,
b; Gin et al. 2011).
Comparative human GPIHBP1 tissue expression
Beigneux et al. (2009b) have previously examined Gpihbp1
tissue expression in mouse tissues and reported high levels of
expression in heart and adipose tissue, which corresponds
with the major distribution for LPL in the body and supports
the key role played by this enzyme in lipid metabolism,
especiallyinheartandadiposetissue(Wionetal.1987;Havel
and Kane 2001). Overall, human GPIHBP1, and mouse and
rat Gpihbp1 genes were moderately expressed in comparison
with the other lymphocyte antigen-like genes being 0.1–0.7
timestheaveragelevelofgeneexpressionincomparisonwith
human LY6E and LYNX1 genes, which showed expression
levels of 4.3 and 1.8 times the average gene, respectively
(Table 1). This may reﬂect a more restricted GPIHBPI cel-
lular expression as compared with LY6-like genes and/or a
more specialized role of GPIHBP1 is being responsible for
LPLbinding in heart andadiposetissueascomparedwiththe
broader and more widely distributed functions of LY6-like
proteins as lymphocyte antigens throughout the body.
Table 5 Predicted N-glycosylation sites for mammalian GPIHBP1 sequences
Mammalian
GPIHBP1
Species Site 1 Site 1
potential
Site 2 Site 2
potential
Site 3 Site 3
potential
Site 4 Site 4
potential
No. of
potential
sites
Human Homo sapiens 78NLTQ 0.76 82NCSH 0.61 2
Orangutan Pongo abelii 78NLTQ 0.76 82NCSH 0.61 2
Rhesus Macaca mulatta 78NLTR 0.69 1
Marmoset Callithrix jacchus 77NLTQ 0.80 1
Mouse Mus musculus 76NQTQ 0.53 1
Rat Rattus norvegicus 84NETQ 0.55 1
Guinea Pig Cavia porcellus 76NQTE NP 150NGTT NP 0
Horse Equus caballus 77NQTQ 0.68 118NKTV 0.70 2
Cow Bos taurus 0
Dog Canis familaris 0
Pig Sus scrofa 0
Predicted N-glycosylation sites were identiﬁed using NetNGlyc 1.0 web tools (http://www.cbs.dtu.dk/services/NetNGlyc/)
32, potential for
N-glycosylation sites was determined by the web tools (maximum level of 1)
Bold values designate high probability of forming an N-glycosylation site
N Asparagine, L leucine, Q glutamine, T threonine, C cysteine, R arginine, E glutamate, H histidine, V valine, NP no prediction for an
N-glycosylation site
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123Gene locations and exonic structures for mammalian
GPIHBP1 genes and human LY6-like genes
Table 1 summarizes the predicted locations for mammalian
GPIHBP1 genes and human LY6-like genes based on
BLAT interrogations of several mammalian genomes using
the reported sequences for human and mouse (Beigneux
et al. 2007; Gin et al. 2007, 2011) and the predicted
sequences for the other mammalian GPIHBP1 proteins and
the UCSC Genome Browser (Kent et al. 2003). Table 2
also presents the predicted locations and other features for
mouse, cow and opossum LY6-like genes and proteins. The
mammalian GPIHBP1 genes were predominantly tran-
scribed on the positive strand, with the exception of the
marmoset and pig genes which were transcribed on the
negative strand. Figure 1 summarizes the predicted exonic
start sites for mammalian GPIHBP1 genes with most
having 4 coding exons in identical or similar positions to
those predicted for the human GPIHBP1 gene, with the
exception of the orangutan GPIHBP1 gene, which con-
tained an additional exon within the encoding region for
the C-terminal sequence. In contrast, the human, mouse,
cow and opossum LY6-like genes examined contained only
3 coding exons encoded on either the positive or negative
strands. These results are indicative of structural similari-
ties between the mammalian GPIHBP1 and LY6-like genes
but with the GPIHBP1 genes possessing an additional exon
(exon 2) in each case.
Figure 3 summarizes the comparative locations of
human, rhesus monkey, mouse, cow and opossum LY6-like
genes within respective gene clusters. Nine human and
rhesus LY6-like and the related GPIHBP1 genes, for
example, were localized within 535 or 618 kb gene clusters,
respectively, on human and rhesus chromosome 8 whereas
15 mouse Ly6-like genes and the Gpihbp1 gene were co-
localized within a 883-kb gene cluster on mouse chromo-
some 15. Cow and opossum (Monodelphis domestica—a
marsupial mammal) LY6-like genes were also similarly
located within respective gene clusters on chromosomes 14
and 3, respectively, although in each case, there were fewer
LY6-like genes identiﬁed in comparison with human and
rhesus genomes, and particularly the mouse genome. Of
special interest to this current study, however, is the absence
of an identiﬁed opossum GPIHBP1-like gene and the
presence of two predicted opossum LY6H-like genes on
chromosome 3 of the opossum genome. For each of the
mammalian genomes examined (human, rhesus monkey,
mouse, cow and opossum), there were similarities in
LY6-like gene order: LYPD2-LYNX1-LY6D-LY6E-LY6H-
GPIHBP1, but with GPIHBP1 being undetected in the case
of the opossum genome.
Figure 4 shows the predicted structures of mRNAs for
human, mouse and rat GPIHBP1 transcripts (Thierry-Mieg
and Thierry-Mieg 2006) which were 2.3–3.1 kbs in length
with three introns and four exons present and in each case,
an extended 30-untranslated region (UTR) was observed.
Fig. 2 Predicted tertiary
structures for the UPAR/Ly6
domain for human, rat, guinea
pig and pig GPIHBP1. Predicted
GPIHBP1 tertiary structures
were obtained using SWISS
MODEL methods; the rainbow
color code describes the tertiary
structures from the N- (blue)t o
C-termini (red color) for
human, rat, guinea pig and pig
GPIHBP1 UPAR/Ly6 domains;
arrows indicate the directions
for b-sheets
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123Evolutionary appearance of the GPIHBP1 gene
in mammalian genomes
Figure 5 shows a UCSC Genome Browser Comparative
Genomics track that shows evolutionary conservation and
alignments of the nucleotide sequences for the human
GPIHBP1 gene, including the 50-ﬂanking, 50-untranslated,
intronic, exonic and 30-untranslated regions of this gene,
with the corresponding sequences for 12 mammalian and
bird genomes, including 4 primates (e.g., rhesus), 6 non-
primate eutherian mammals (e.g., mouse, rat), a marsupial
(opossum), a monotreme (platypus) and a bird species
(chicken). Extensive conservation was observed among
these GPIHBP1 genomic sequences for the eutherian
mammalian genomes, particularly for the primate species
but also for the exonic and 50-ﬂanking regions for all
eutherian genomes examined. An examination of non-
synonymous (ns) single nucleotide polymorphisms (SNPs)
within the human genome supported this conclusion of
GPIHBP1 conservation with this gene containing only a
single ns-SNP within exon 1. In contrast with the eutherian
mammalian genomes examined, the opossum (marsupial
mammal) genome lacked conserved sequences within the
50-ﬂanking and exon 1 and 2 regions, but showed some
genomic sequence conservation within the exon 3 and exon
4 regions. The platypus (monotreme mammal) exhibited
conserved GPIHBP1 gene sequences within the 50-ﬂanking
and exon 3 and 4 regions but showed no conservation of
other sections of this gene, and lacked exon 1 and 2 con-
served sequences. In addition, the chicken (bird) genomic
sequence showed no signiﬁcant conservation of any region
of the GPIHBP1 gene, which is consistent with BLAT
Fig. 3 Comparative gene
clusters for mammalian LY6-
like genes. LY6-like gene
clusters are identiﬁed with the
size of the cluster (in kilobases)
in each case. Individual LY6-
like genes were identiﬁed and
positioned using data
summarized in Tables 1 and 2.
The arrow shows the direction
for transcription: right arrow
the positive strand; left arrow
the negative strand. Note the
absence of an identiﬁed
GPIHBP1 gene on the opossum
genome
Fig. 4 Gene and mRNA
structures for the human, mouse
andratGPIHBP1genes.Derived
from the AceView website
http://www.ncbi.nlm.nih.gov/
IEB/Research/Acembly/
(Thierry-MiegandThierry-Mieg
2006); mature isoform variants
(a) are shown with capped
50- and 30-ends for the predicted
mRNA sequences. NM refers to
the NCBI reference sequence.
Exons are in shaded pink;
untranslated 50- and30 sequences
are in open pink, introns are
represented as pink lines joining
exons, the directions for tran-
scription are shown as 50?30,
sizes of mRNA sequences are
shown in kilobases (kb)
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123analyses undertaken using mammalian GPIHBP1 protein
sequences which failed to identify a GPIHBP1 gene in this
bird genome. It would appear that GPIHBP1 has only
recently evolved during mammalian evolution and that the
functional gene is present only in eutherian mammalian
genomes.
Phylogeny and divergence of mammalian GPIHBP1
and LY6-like sequences
A phylogenetic tree (Fig. 6) was calculated by the pro-
gressive alignment of 11 mammalian GPIHBP1 amino acid
sequences with human, mouse, cow and opossum LY6-like
sequences which was ‘rooted’ with the zebraﬁsh (Danio
rerio) LYPD6 sequence (Tables 1, 2). The phylogram
showed clustering of the sequences into groups which were
consistent with their evolutionary relatedness as well as
distinct groups for mammalian GPIHBP1 and LY6-like
sequences, which were distinct from the zebraﬁsh LYPD6
sequence. In addition, the mammalian LY6-like sequences
were further subdivided into groups, including PSCA,
LYNX1, LY6D, LY6H, SLURP1, LYPD2, LY6E, LY6K,
GML and a group of mouse Ly6-like sequences (desig-
nated as Ly6a, Ly6c1, Ly6c2, Ly6f and Ly6i). These
groups were signiﬁcantly different from each other (with
bootstrap values [90) and have apparently evolved as
distinct genes and proteins during mammalian evolution.
Moreover, it is apparent that GPIHBP1 is a distinct but
related LY6-like gene which has appeared early in euthe-
rian mammalian evolution.
Hypothesis: proposed mechanism for the evolutionary
appearance of GPIHBP1 in eutherian mammals
A search was undertaken for a potential gene ‘donor’ for the
exon encoding the acidic amino acid motif contained within
the mammalian GPIHBP1 gene using BLAT to interrogate
the human genome with the known nucleotide sequence for
exon 2 of the human GPIHBP1 gene (Kent et al. 2003). A
regionofthehumanBCL11Agene(encodingacidicresidues
Fig. 5 Comparative sequences for mammalian 50-ﬂanking, 50-
untranslated and coding regions for the GPIHBP1 genes. Derived
from the UCSC Genome Browser using the Comparative Genomics
track to examine alignments and evolutionary conservation of
GPIHBP1 gene sequences; genomic sequences aligned for this study
included primate (human, orangutan, rhesus and marmoset), non-
primate eutherian mammal (mouse, rat, guinea pig, dog, horse and
cow), a marsupial (opossum), a monotreme (platypus) and bird
species (chicken); conservation measures were based on conserved
sequences across all of these species in the alignments which included
the 50-ﬂanking, 50-untranslated, exons, introns and 30-untranslated
regions for the GPIHBP1 gene; regions of sequence identity are
shaded in different colors for different species
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123484–504 of human B-cell CLL/lymphoma 11A) was iden-
tiﬁed which encoded an extended sequence of acidic amino
acids comparable to amino acid residues 25–50 (corre-
sponding to residues encoded by exon 2 of human
GPIHBP1) in the human GPIHBP1 sequence. Supplemen-
tary Fig. 1 shows an alignment of this region for represen-
tative vertebrate BCL11A acidic amino acid sequences with
several mammalian GPIHBP1 exon 2 sequences. Similari-
ties in acidic amino acid sequences are apparent although
each protein exhibited a distinctive conservation pattern. It
maybenotedthattheBCL11Ageneandproteincanbetraced
back to reptiles and ﬁsh in vertebrates (Table 3) whereas
GPIHBP1 has been only reported in eutherian mammals
(Table 1). Previous studies have shown that the mouse
Bcl11agene encodesaC2H2-typezinc-ﬁngerproteinwhich
is a common site of retroviral integration in myeloid leuke-
mia and functions as a myeloid and B-cell proto-oncogene
(Nakamuraetal.2000)andmayserveasacandidategenefor
thetransferandintegrationoftheacidicaminoacidencoding
‘motif’ into the mammalian GPIHBP1 gene. A hypothesis
concerning the evolutionary appearance of the ‘ancestral’
eutherian mammalian GPIHBP1 gene ispresented in Fig. 7.
10%
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Fig. 6 Phylogenetic tree of
mammalian GPIHBP1 and other
LY6-like sequences. The tree is
labeled with the gene name and
the name of the animal and is
‘rooted’ with the zebraﬁsh
(Danio rerio) LY6PD sequence.
Note the major cluster for the
mammalian GPIHBP1
sequences and several major
groups of the other LY6-like
sequences: LYNX1, LY6D,
LY6H, SLURP1, LYPD2,
PSCA, LT6E, LY6K, and GML.
A genetic distance scale is
shown (% amino acid
substitutions). The number of
times a clade (sequences
common to a node or branch)
occurred in the bootstrap
replicates are shown. Only
replicate values of 90 or more
which are highly signiﬁcant are
shown with 100 bootstrap
replicates performed in each
case
Fig. 7 Proposal for generating
the GPIHBP1 gene during
eutherian mammalian evolution.
This hypothesis is for a two-step
process for generating the
GPIHBP1 gene: (1) a LY6-like
gene duplication event in a
common ancestor for eutherian
mammals; and (2) retroviral
transfer of a region of the
BCL11A gene in the ancestral
genome encoding acidic amino
acids generating a GPIHBP1-
like gene containing a new exon
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123Step 1 An LY6-like gene within a common ancestor to
eutherian mammals underwent a tandem duplica-
tion event generating two closely related LY6-like
genes. It may be noted that the opossum genome
contains similar LY6H genes (designated as
LY6H1 and LY6H2) which are closely localized
on opossum chromosome 3 (Fig. 3) and form a
distinct opossum LY6-like group following
CLUSTAL analysis (Fig. 6); and
Step 2 Retroviral integration of the acidic amino acid
encoding ‘motif’ of the ancestral BCL11A gene
may have occurred in one of the duplicated LY6-
like genes (potentially a LY6H-like gene or
another LY6-like gene) resulting in the addition
of an exon (exon 2) which during the subsequent
evolution generates an ancestral eutherian mam-
malian GPIHBP1-like gene and protein which is
retained throughout subsequent eutherian mam-
malian evolution.
Conclusions
The results of the present study indicate that the mamma-
lian GPIHBP1 gene and encoded protein recently reported
represents a distinct family of lymphocyte antigen-6 (LY6)-
related gene and protein which shares key conserved
sequences and functions with other LY6-like genes and
proteins previously studied (Brakenoff et al. 1995; Capone
et al. 1996; Clark et al. 2003; Horie et al. 1998; Ishikawa
et al. 2007). GPIHBP1 is encoded by a single gene among
the mammalian genomes studied which is localized within
a LY6-like gene cluster (*500 kbs) on human chromo-
some 8 and usually contained 4 coding exons. Predicted
secondary structures for mammalian GPIHBP1 proteins
showed a strong similarity with other LY6-like proteins in
a number of domains, including the N-terminal signal
peptide region, the UPAR-LY6 domain and in having a
highly hydrophobic C-terminal helical sequence, which is
removed in the endoplasmic reticulum during the forma-
tion of the glycosylphosphatidylinositol anchor. In contrast,
however, all mammalian GPIHBP1 proteins contained two
high acidic amino acid regions, which have been proposed
to play a role in binding LPL (Beigneux et al. 2007; Gin
et al. 2007, 2011). Predicted secondary and tertiary struc-
tures of the UPAR-LY6 mammalian GPIHBP1 domain
showed a strong resemblance to the corresponding region
for the human CD59 antigen structure (Leath et al. 2007)
with ﬁve anti-parallel b-sheets. Comparative studies of 12
mammalian GPIHBP1 genomic sequences indicated that
this gene has appeared during eutherian mammalian evo-
lution with conserved genomic sequences observed for all
eutherian mammalian genomes examined. In contrast,
GPIHBP1 gene sequences were absent from the chicken
genome or were seen only in part for the monotreme and
marsupial genomes examined. It is proposed that the
GPIHBP1 gene has appeared early in mammalian evolu-
tion following a tandem gene duplication event of one of
the LY6 genes and the subsequent retroviral integration of
exon 2 encoding the acidic amino acid ‘motif’.
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